Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Phase II study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer
Oncology (Karger), 09/08/09
Tsunoda A et al. – Combined treatment with S-1 and irinotecan is an effective, well-tolerated, and convenient regimen in patients with advanced CRC.
Methods- S-1 was administered orally at 80 mg/m2/d x 21d followed by a 2-week rest
- Courses were repeated q5w
- 40 patients with advanced CRC
- CR = 1; PR = 24
- ORR = 62.5%
- Median PFS = 7.8 mos
- Grade 3 or 4 toxicities (neutropenia [12.5%], anorexia [12.5%], fatigue [10%], and diarrhea [7.5%]
Related Articles
The impact of new treatment options for advanced colorectal cancer on routine care: results of a retrospective analysis of 206 consecutive patients treated in a community-based oncology group practice in Germany
European Journal of Cancer Care, 10/27/09
Relevance Score: 83%
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature
Annals of Oncology, 11/16/09
Relevance Score: 82%
Down-regulation of Tip60 Gene as a Potential Marker for the Malignancy of Colorectal Cancer
Anticancer Research, 11/10/09
Relevance Score: 81%
The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy
Annals of Oncology, 11/03/09
Relevance Score: 81%
Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study
Journal of Clinical Oncology, 10/02/09
Relevance Score: 81%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients
Cancer Prevention Research, 12/06/09
EORTC Elderly Task Force experts opinion for the treatment of colon cancer in older patients
Cancer Treatment Reviews, 12/04/09
Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
Annals of Oncology, 12/04/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Hormonal deprivation therapy-induced osteoporosis in postmenopausal women with breast cancer
Best Practice & Research: Clinical Rheumatology, 12/07/09
Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients
Cancer Prevention Research, 12/06/09
Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer
BMC Cancer, 12/06/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


